Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na(+)/K(+)-ATPase-density

PURPOSE: Tumour blood flow (TBF) is a crucial determinant of cancer growth. Recently, we validated Rubidium-82 ((82)Rb) positron emission tomography (PET) for TBF measurement in prostate cancer (PCa) and found TBF and cancer aggressiveness positively correlated. The aims of the present study were to...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Eur J Nucl Med Mol Imaging
Главные авторы: Jochumsen, Mads Ryø, Sörensen, Jens, Pedersen, Bodil Ginnerup, Nyengaard, Jens Randel, Krag, Søren Rasmus Palmelund, Frøkiær, Jørgen, Borre, Michael, Bouchelouche, Kirsten, Tolbod, Lars Poulsen
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7835182/
https://ncbi.nlm.nih.gov/pubmed/32808078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04998-2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы